| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| October 28, 2025 | ±2.1% | -0.6% | over-priced |
| July 29, 2025 | ±1.9% | +0.7% | over-priced |
| April 29, 2025 | ±3.0% | +0.4% | over-priced |
| October 29, 2024 | ±2.0% | -0.9% | over-priced |
| July 30, 2024 | ±1.8% | +0.9% | over-priced |
| April 30, 2024 | ±1.9% | -0.7% | over-priced |
| October 27, 2023 | ±3.6% | -2.8% | over-priced |
| July 28, 2023 | ±3.1% | +1.4% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q4 FY2025 | $0.30 | $410M | $523M |
| Q3 FY2025 | $0.41 | $424M | $633M |
| Q2 FY2025 | $0.34 | $377M | $542M |
| Q1 FY2025 | $0.34 | $351M | $531M |
Huntington Bancshares Inc (HBAN) reports imminently, with the next report estimated for April 26, 2026. Across the last 8 reports, options priced an average ±2.4% earnings move while the stock actually moved 1.1% on average — the market has systematically over-priced HBAN's earnings risk. Fundamentals into the print: EPS down 9.1% year-over-year, revenue up 13.3%. QuantLogix's live 5-factor engine currently reads HBAN as a buy at 59/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →